Photo by nci from unsplash
Percutaneous mitral valve repair for symptomatic severe mitral regurgitation has rapidly evolved as a viable therapeutic option for high‐surgical risk patients. Both randomized clinical studies as well as real world… Click to show full abstract
Percutaneous mitral valve repair for symptomatic severe mitral regurgitation has rapidly evolved as a viable therapeutic option for high‐surgical risk patients. Both randomized clinical studies as well as real world registry data have demonstrated significant improvement in severity of MR and clinical outcomes. In carefully selected patients with severely reduced left ventricular systolic function and severe symptomatic MR, Mitraclip therapy seems to show promise.
Keywords:
mitraclip therapy;
ventricular systolic;
severity left;
left ventricular
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!
Journal Title: Catheterization and Cardiovascular Interventions
Year Published: 2017
Link to full text (if available)
Share on Social Media: Sign Up to like & get
recommendations!